R Sedrani1, S Cottens, J Kallen, W Schuler. Show Affiliations » 1. Novartis Pharma AG, Basel, Switzerland.
Abstract
Entities: Disease
Mesh: See more » AnimalsCarrier Proteins/metabolismDNA-Binding Proteins/metabolismDrug DesignEverolimusHeat-Shock Proteins/metabolismImmunosuppressive Agents/chemistryImmunosuppressive Agents/metabolismImmunosuppressive Agents/pharmacologyLymphocyte Culture Test, MixedMiceMice, Inbred BALB CMice, Inbred CBAMolecular StructurePolyenes/chemistryPolyenes/metabolismPolyenes/pharmacologySirolimusStructure-Activity RelationshipTacrolimus Binding Proteins
Substances: See more » Carrier ProteinsDNA-Binding ProteinsHeat-Shock ProteinsImmunosuppressive AgentsPolyenesEverolimusTacrolimus Binding ProteinsSirolimus
Year: 1998 PMID: 9723437 DOI: 10.1016/s0041-1345(98)00587-9
Source DB: PubMed Journal: Transplant Proc ISSN: 0041-1345 Impact factor: 1.066